Aesthetics
Sculptra vs. Radiesse: What’s the Difference?
How poly-L-lactic acid and calcium hydroxylapatite compare on what they are made of, how quickly they show, where the FDA has approved them and what can go wrong.
Sculptra and Radiesse are both collagen stimulators, but they are made of different materials and behave differently. Sculptra is poly-L-lactic acid (PLLA), a powder mixed with sterile water that works gradually over several sessions (U.S. Food and Drug Administration [FDA], 2023b). Radiesse is calcium hydroxylapatite (CaHA) in a gel that adds some visible volume right away and is also used diluted for skin quality (FDA, 2026). Neither is dissolvable the way hyaluronic acid filler is, and the better fit depends on the area, the goal and the person's history.
What This Means
A collagen stimulator is an injectable implant that aims to prompt the body to build its own collagen around the injected material. The FDA regulates both products as dermal filler devices, approved for specific uses in adults 22 and older (FDA, 2023a).
Sculptra contains PLLA, carboxymethylcellulose and mannitol. It is reconstituted with sterile water before use. The FDA has approved it for correction of fine lines and wrinkles in the cheek region of people with a normal immune response, among other facial indications (FDA, 2023b).
Radiesse contains synthetic CaHA microspheres of 25 to 45 microns suspended in a gel of glycerin, sodium carboxymethylcellulose and sterile water. Its approved uses include moderate to severe facial wrinkles and folds such as nasolabial folds (the lines from the nose to the corners of the mouth), facial fat loss in people with HIV, volume loss on the back of the hands and, since March 2026, décolleté wrinkles when diluted with saline (FDA, 2026).
The particles also differ. A laboratory study found Radiesse particles were smooth and spherical, while Sculptra particles were irregular flakes that varied widely in size (McCarthy et al., 2024). That helps explain why the two are injected, dosed and paced differently.
Candidacy
Both products are for adults who want gradual, structural improvement rather than a fixed look. People who want an immediate, easily adjusted result in a small area such as the lips are usually steered toward hyaluronic acid filler instead.
Some people should not receive them. Sculptra's labeling excludes people with a history of keloids or hypertrophic scarring (raised, thick scars), severe allergies with a history of anaphylaxis, or hypersensitivity to its components (FDA, 2023b). Radiesse is contraindicated in people with severe allergies or bleeding disorders (FDA, 2026). The FDA also notes that safety in pregnancy and breastfeeding is unknown, and that injection should wait if the skin is inflamed or infected (FDA, 2023a).
Clinical Evaluation
At PrimeCell Regenerative, Dr. Chantasi reviews medical history, medications and supplements that affect bleeding, prior filler or implant history, scarring tendency and allergies. He then looks at the face or area in question: where volume has been lost, how thin the skin is, and whether lines come from volume loss, skin laxity or muscle movement.
That last point matters. Lines caused mainly by muscle movement respond to neuromodulators, not collagen stimulators. Candidacy is a physician decision made at an evaluation, not a product choice made in advance.
Available Options
Sculptra and Radiesse are two of several FDA-approved options. Others include:
- Hyaluronic acid fillers such as Juvéderm and Restylane, which give immediate volume and can usually be dissolved.
- Neuromodulators such as Botox for lines from muscle movement.
- Energy-based devices, chemical peels and microneedling for texture and fine lines.
- Daily sunscreen and prescription topical retinoids for long-term skin quality.
- Surgical options, such as a facelift or fat grafting, for significant laxity or volume loss.
- Choosing to do nothing, which is a reasonable option.
Benefits, Limitations and Risks
Timing. Sculptra works slowly. In the cheek study, people received up to four injection sessions to reach their best result, and results lasted up to 24 months (FDA, 2023b). Radiesse shows some change right away because the gel itself adds volume, with collagen building over the following months.
Reversibility. Neither product can be reliably reversed. The FDA warns that fillers not made of hyaluronic acid may be difficult or impossible to remove (FDA, 2023a). That is the main reason these products call for a conservative plan.
Common side effects. Redness, bruising, swelling, tenderness, itching and small lumps are common with both (FDA, 2023a). In the Radiesse décolleté study, most of these were mild to moderate and settled within two weeks (FDA, 2026).
Less common and serious risks. Nodules and granulomas (firm bumps under the skin) can develop, sometimes months later (FDA, 2023a). The most serious risk with any filler is accidental injection into a blood vessel, which can cause tissue death, vision loss or stroke (FDA, 2023a). Post-market reports for Radiesse include vascular occlusion and visual impairment, including blindness (FDA, 2026). These events are rare, but they are the reason injector training and anatomy knowledge matter.
What the Evidence Shows
The evidence does establish that both products improve the specific areas they were studied in. The FDA approved Sculptra for cheek wrinkles in 2023 based on a clinical study, with results that may last up to 24 months (FDA, 2023b). In the Radiesse décolleté trial, 71.2% of people who received it improved by at least one grade at 24 weeks, compared with 6.3% of a comparison group that had not yet received it (FDA, 2026). Systematic reviews of PLLA and of CaHA in the face report generally favorable results with acceptable safety (Signori et al., 2024; Guida & Galadari, 2024).
The evidence does not establish that one is better than the other. Large randomized trials comparing Sculptra and Radiesse directly are lacking, and both systematic reviews note that studies vary in design and quality (Signori et al., 2024; Guida & Galadari, 2024). Laboratory work on particle shape and tissue response is useful background, but it does not predict how an individual face will look (McCarthy et al., 2024). The FDA also notes that the safety of repeated filler use over long periods has not been evaluated in controlled studies (FDA, 2023a).
Recovery and Next Steps
Most people return to normal activity the same day, with some swelling or bruising for several days. Sculptra plans usually include post-injection massage instructions from the injector. Radiesse plans may involve one session for a facial fold or a series of sessions for skin quality; the décolleté study used three sessions six weeks apart (FDA, 2026).
Get care right away for unusual pain, skin that turns white, gray or blue near the injection site, vision changes or any sign of stroke during or shortly after injection (FDA, 2023a).
Orlando Considerations
Central Florida has many injection providers. Before any filler, confirm the injector's Florida license, ask which product is being used and ask to see the packaging. The FDA advises against fillers bought online or injected at home (FDA, 2023a). Sun exposure is year-round here, so daily sunscreen is part of any plan to protect skin quality.
Frequently asked questions
Which lasts longer, Sculptra or Radiesse?
There is no head-to-head answer. In the study behind Sculptra’s cheek approval, results may last up to 24 months (FDA, 2023b). In the Radiesse décolleté study, more than 60% of people still met the improvement threshold at 60 weeks (FDA, 2026). Duration varies by person, area and amount used, and it is not guaranteed.
Can Sculptra or Radiesse be dissolved if I don’t like the result?
Not reliably. Unlike hyaluronic acid filler, fillers made of other materials may be difficult or impossible to remove, and removal can require injections or surgery with their own risks (FDA, 2023a). This is why a cautious, staged plan makes sense.
Are Sculptra and Radiesse FDA-approved?
Yes, both are FDA-approved devices for specific uses. Sculptra is approved for facial indications including cheek wrinkles (FDA, 2023b). Radiesse is approved for facial wrinkles and folds, HIV-related facial fat loss, the back of the hands and, in diluted form, décolleté wrinkles (FDA, 2026). Use in other areas is off-label.
How many sessions does each one take?
Sculptra is usually given as a series; in the cheek study people had up to four sessions (FDA, 2023b). Radiesse is often a single session for a facial fold, while the décolleté plan used three sessions six weeks apart (FDA, 2026). The number for any individual is set at an evaluation.
Can they be combined with Botox or each other?
Some clinicians combine products, but the FDA notes that the safety of fillers used together with neuromodulators or other procedures has not been evaluated in controlled clinical studies (FDA, 2023a). Any combination should be discussed openly, including what is known and what is not.
References
- Guida, S., & Galadari, H. (2024). A systematic review of Radiesse/calcium hydroxylapatite and carboxymethylcellulose: Evidence and recommendations for treatment of the face. International Journal of Dermatology, 63(2), 150–160. https://doi.org/10.1111/ijd.16888
- McCarthy, A. D., Hartmann, C., Durkin, A., Shahriar, S., Khalifian, S., & Xie, J. (2024). A morphological analysis of calcium hydroxylapatite and poly-l-lactic acid biostimulator particles. Skin Research and Technology, 30, e13764. https://doi.org/10.1111/srt.13764
- Signori, R., de Paula Barbosa, A., Cezar-dos-Santos, F., Carbone, A. C., Ventura, S., Brissian de Souza Nobre, B., Boechat Borges Neves, M. L., Barbosa Câmara-Souza, M., Lorenzi Poluha, R., & De la Torre Canales, G. (2024). Efficacy and safety of poly-L-lactic acid in facial aesthetics: A systematic review. Polymers, 16(18), 2564. https://doi.org/10.3390/polym16182564
- U.S. Food and Drug Administration. (2023a). Dermal fillers (soft tissue fillers). https://www.fda.gov/medical-devices/aesthetic-cosmetic-devices/dermal-fillers-soft-tissue-fillers
- U.S. Food and Drug Administration. (2023b). Sculptra – P030050/S039. https://www.fda.gov/medical-devices/recently-approved-devices/sculptra-p030050s039
- U.S. Food and Drug Administration. (2026). Summary of safety and effectiveness data: RADIESSE injectable implant (PMA P050052/S162). https://www.accessdata.fda.gov/cdrh_docs/pdf5/P050052S162B.pdf
This article is general education about FDA-approved injectable devices and is not a substitute for individual medical advice. Candidacy is determined by a licensed provider at an individual evaluation. Individual results vary, results and duration are not guaranteed, and options are discussed after a medical evaluation.
